{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:57:24Z","timestamp":1791219444898,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,18]]},"DOI":"10.7759\/cureus.84318","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T08:59:44Z","timestamp":1747558784000},"source":"Crossref","is-referenced-by-count":4,"title":["Suicidal Ideation and Suicide Completion in Benzodiazepine Users: A Systematic Review of Current Evidence"],"prefix":"10.7759","author":[{"given":"Safiyyah M","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alousious","family":"Kasagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushka","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiman","family":"Saraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehjabin S","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithum","family":"Senaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safeera","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.16r02037","article-title":"Prescribed benzodiazepines and suicide risk: a review of the literature","volume":"19","author":"Dodds TJ","year":"2017","unstructured":"Dodds TJ. Prescribed benzodiazepines and suicide risk: a review of the literature. Prim Care Companion CNS Disord. 2017, 19:10.4088\/PCC.16r02037","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7020017","article-title":"Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives","volume":"7","author":"Guina J","year":"2018","unstructured":"Guina J, Merrill B. Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives. J Clin Med. 2018, 7:17. 10.3390\/jcm7020017","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13582","article-title":"Risk of suicide attempt and suicide associated with benzodiazepine: a nationwide case crossover study","volume":"148","author":"Tournier M","year":"2023","unstructured":"Tournier M, B\u00e9nard-Laribi\u00e8re A, Jollant F, et al.. Risk of suicide attempt and suicide associated with benzodiazepine: a nationwide case crossover study. Acta Psychiatr Scand. 2023, 148:233-41. 10.1111\/acps.13582","journal-title":"Acta Psychiatr Scand"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, et al.. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021, 372:n160. 10.1136\/bmj.n160","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2019.11.005","article-title":"Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders","volume":"62","author":"Boggs JM","year":"2019","unstructured":"Boggs JM, Lindrooth R, Battaglia C, et al.. Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders. Gen Hosp Psychiatry. 2019, 62:21-7. 10.1016\/j.genhosppsych.2019.11.005","journal-title":"Gen Hosp Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-019-2312-3","article-title":"Association between benzodiazepines and suicide risk: a matched case-control study","volume":"19","author":"Cato V","year":"2019","unstructured":"Cato V, Holl\u00e4ndare F, Nordenskj\u00f6ld A, Sellin T. Association between benzodiazepines and suicide risk: a matched case-control study. BMC Psychiatry. 2019, 19:317. 10.1186\/s12888-019-2312-3","journal-title":"BMC Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109046","article-title":"Concomitant opioid and benzodiazepine use and risk of suicide attempt and intentional self-harm: pharmacoepidemiologic study","volume":"228","author":"Gibbons RD","year":"2021","unstructured":"Gibbons RD, Hur K, Quinn PD. Concomitant opioid and benzodiazepine use and risk of suicide attempt and intentional self-harm: pharmacoepidemiologic study. Drug Alcohol Depend. 2021, 228:109046. 10.1016\/j.drugalcdep.2021.109046","journal-title":"Drug Alcohol Depend"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09250-y","article-title":"Epidemiologic assessment of benzodiazepine exposure among suicide deaths in Colorado, 2015-2017","volume":"20","author":"Ghosh T","year":"2020","unstructured":"Ghosh T, Bol K, Butler M, Gabella B, Kingcade A, Kaplan G, Myers L. Epidemiologic assessment of benzodiazepine exposure among suicide deaths in Colorado, 2015-2017. BMC Public Health. 2020, 20:1149. 10.1186\/s12889-020-09250-y","journal-title":"BMC Public Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/20451253221082386","article-title":"Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey","volume":"12","author":"Reid Finlayson AJ","year":"2022","unstructured":"Reid Finlayson AJ, Macoubrie J, Huff C, Foster DE, Martin PR. Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey. Ther Adv Psychopharmacol. 2022, 12:20451253221082386. 10.1177\/20451253221082386","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2140723","article-title":"Withdrawal from long-term use of unusually high-dose oxazepam","volume":"2021","author":"Mustonen A","year":"2021","unstructured":"Mustonen A, Leijala J, Aronranta J, Lassila A, Aalto M, Koskim\u00e4ki J. Withdrawal from long-term use of unusually high-dose oxazepam. Case Rep Psychiatry. 2021, 2021:2140723. 10.1155\/2021\/2140723","journal-title":"Case Rep Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201800321","article-title":"Benzodiazepine use and misuse among adults in the United States","volume":"70","author":"Maust DT","year":"2018","unstructured":"Maust DT, Lin LA, Blow FC. Benzodiazepine use and misuse among adults in the United States. Psychiatr Serv. 2018, 70:97-106. 10.1176\/appi.ps.201800321","journal-title":"Psychiatr Serv"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.48557","article-title":"Benzodiazepine discontinuation and mortality among patients receiving long-term benzodiazepine therapy","volume":"6","author":"Maust DT","year":"2023","unstructured":"Maust DT, Petzold K, Strominger J, Kim HM, Bohnert AS. Benzodiazepine discontinuation and mortality among patients receiving long-term benzodiazepine therapy. JAMA Netw Open. 2023, 6:e2348557. 10.1001\/jamanetworkopen.2023.48557","journal-title":"JAMA Netw Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.17130","article-title":"Comparative effectiveness of pharmacotherapies for the risk of attempted or completed suicide among persons with borderline personality disorder","volume":"6","author":"Lieslehto J","year":"2023","unstructured":"Lieslehto J, Tiihonen J, L\u00e4hteenvuo M, Mittendorfer-Rutz E, Tanskanen A, Taipale H. Comparative effectiveness of pharmacotherapies for the risk of attempted or completed suicide among persons with borderline personality disorder. JAMA Netw Open. 2023, 6:e2317130. 10.1001\/jamanetworkopen.2023.17130","journal-title":"JAMA Netw Open"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s1047-2797(97)00126-9","article-title":"Risk of suicide attempts after benzodiazepine and\/or antidepressant use","volume":"7","author":"Neutel CI","year":"1997","unstructured":"Neutel CI, Patten SB. Risk of suicide attempts after benzodiazepine and\/or antidepressant use. Ann Epidemiol. 1997, 7:568-74. 10.1016\/s1047-2797(97)00126-9","journal-title":"Ann Epidemiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/comp.2002.35912","article-title":"Suicide attempts in high-dose benzodiazepine users","volume":"43","author":"Lekka NP","year":"2002","unstructured":"Lekka NP, Paschalis C, Beratis S. Suicide attempts in high-dose benzodiazepine users. Compr Psychiatry. 2002, 43:438-42. 10.1053\/comp.2002.35912","journal-title":"Compr Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.115857","article-title":"Risk of suicide attempts and intentional self-harm on alprazolam","volume":"335","author":"Gibbons RD","year":"2024","unstructured":"Gibbons RD, Hur K, Lavigne JE, Mann JJ. Risk of suicide attempts and intentional self-harm on alprazolam. Psychiatry Res. 2024, 335:115857. 10.1016\/j.psychres.2024.115857","journal-title":"Psychiatry Res"},{"key":"ref17","unstructured":"National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. (2011). https:\/\/www.nice.org.uk\/guidance\/cg113."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1060949","article-title":"GABAA receptor subtypes and benzodiazepine use, misuse, and abuse","volume":"13","author":"Engin E","year":"2023","unstructured":"Engin E. GABAA receptor subtypes and benzodiazepine use, misuse, and abuse. Front Psychiatry. 2023, 13:1060949. 10.3389\/fpsyt.2022.1060949","journal-title":"Front Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/358611-suicidal-ideation-and-suicide-completion-in-benzodiazepine-users-a-systematic-review-of-current-evidence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T08:59:45Z","timestamp":1747558785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/358611-suicidal-ideation-and-suicide-completion-in-benzodiazepine-users-a-systematic-review-of-current-evidence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,18]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.84318","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,18]]}}}